Chronic Sore Throat

Chapter

Abstract

Chronic sore throat is usually caused by non-infectious processes, such as gastrointestinal reflux. Autoimmune diseases, such as pemphigus vulgaris and mucous membrane pemphigoid, are less common etiologies. Malignancy is important to exclude in any patient with chronic throat pain or hoarseness. Infectious causes of these symptoms include Mycobacterium tuberculosis and various types of fungi, such as Candida, Cryptococcus, and endemic fungi (Histoplasma, Blastomyces, Coccidioides, and Paracoccidioides). This chapter reviews the epidemiology and clinical manifestations of various non-infectious and infectious causes of chronic sore throat.

Keywords

Chronic sore throat Chronic pharyngitis Chronic laryngitis Extrapulmonary tuberculosis Oropharyngeal histoplasmosis 

References

  1. 1.
    Yazici ZM, Sayin I, Kayhan FT, Biskin S. Laryngopharyngeal reflux might play a role in chronic nonspecific pharyngitis. Eur Arch Otorhinolaryngol. 2010;267(4):571.CrossRefPubMedGoogle Scholar
  2. 2.
    Poelmans J, Tack J. Extraoesophageal manifestations of gastro-oesophageal reflux. Gut. 2005;54:1492–9.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Ford CN. Evaluation and management of laryngopharyngeal reflux. JAMA. 2005;294:1534–40.CrossRefPubMedGoogle Scholar
  4. 4.
    Kamargiannis N, Gouveris H, Katsinelos P, et al. Chronic pharyngitis is associated with severe acidic laryngopharyngeal reflux in patients with Reinke's edema. Ann Otol Rhinol Laryngol. 2011;120:722–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Bannister M. Tonsillitis caused by vomiting in a patient with bulimia nervosa: a case report and literature review. Case Rep Otolaryngol. 2013;2013:251629.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Nehra D, Goldstein AM. Intestinal malrotation: varied clinical presentation from infancy through adulthood. Surgery. 2011;149:386–93.CrossRefPubMedGoogle Scholar
  7. 7.
    Renner B, Mueller CA, Shephard A. Environmental and non-infectious factors in the aetiology of pharyngitis (sore throat). Inflamm Res. 2012;61:1041–52.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Webber MP, Gustave J, Lee R, et al. Trends in respiratory symptoms of fire fighters exposed to the world trade center disaster: 2001–2005. Environ Health Perspect. 2009;117:975–80.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Ata-Ali F, Ata-Ali J. Pemphigus vulgaris and mucous membrane pemphigus: Update of etiopathogenesis, oral manifestations and management. J Clin Exp Dent. 2011;3:3246–50.Google Scholar
  10. 10.
    Magliocca KR, Fitzpatrick SG. Autoimmune disease manifestations in the oral cavity. Surg Pathol Clin. 2017;10:57–88.CrossRefPubMedGoogle Scholar
  11. 11.
    Lambiel S, Dulguerov P, Laffitte E, Leuchter I. Paraneoplastic mucous membrane pemphigoid with ocular and laryngeal involvement. BMJ Case Rep. 2017;11:2017.Google Scholar
  12. 12.
    Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013;381:320–32.CrossRefPubMedGoogle Scholar
  13. 13.
    Xu HH, Werth VP, Parisi E, Sollecito TP. Mucous membrane pemphigoid. Dent Clin N Am. 2013;57:611–30.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Scully C, Lo Muzio L. Oral mucosal diseases: mucous membrane pemphigoid. Br J Oral Maxillofacial Surg. 2008;46:358–66.CrossRefGoogle Scholar
  15. 15.
    Chan LS, Ahmed AR, Anhalt GJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138:370–9.PubMedGoogle Scholar
  16. 16.
    Scully C. Clinical practice. Aphthous ulceration. N Engl J Med. 2006;355:165–72.CrossRefGoogle Scholar
  17. 17.
    Neville BW, Damm DD, Allen CM, Bouquot JE. Oral and maxillofacial pathology. 3rd ed. Philadelphia: W. B. Saunders; 2008. p. 331–6.Google Scholar
  18. 18.
    Munoz-Corcuera M, Esparza-Gomez G, Gonzalez-Moles MA, et al. Oral ulcers: clinical aspects. A tool for dermatologists. Part II. Chronic ulcers. Clin Exp Dermatol. 2009;34:456–61.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Arduino PG, Porter SR. Herpes simplex virus type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med. 2008;17:107–21.Google Scholar
  20. 20.
    Zhang S, Farmer TL, Frable MA, et al. Adult herpetic laryngitis with concurrant candidal infection: a case report and literature review. Arch Otolaryngol Head Neck Surg. 2000;126:672–4.CrossRefPubMedGoogle Scholar
  21. 21.
    Scully C, Flint S. Color atlas of oral diseases. New York: Lippincott; 1989.Google Scholar
  22. 22.
    Lin YY, Kao CH, Wang CH. Varicella zoster virus infection of the pharynx and larynx with multiple cranial neuropathies. Laryngoscope. 2011;121:1627–30.CrossRefPubMedGoogle Scholar
  23. 23.
    Chitose SI, Umeno H, Hamakawa S, et al. Unilateral associated laryngeal paralysis due to varicella zoster virus: virus antibody testing and videofluoroscopic findings. J Laryngol Otol. 2008;122:1170–8.CrossRefGoogle Scholar
  24. 24.
    Choi JH. Two cases of pharyngolaryngeal zoster advanced to multiple cranial neuropathy. Am J Otolaryngol. 2013;34:369–72.CrossRefPubMedGoogle Scholar
  25. 25.
    Nisa L, Landis BN, Giger R, et al. Pharyngolaryngeal involvement by varicella-zoster virus. J Voice. 2013;27:636–41.CrossRefPubMedGoogle Scholar
  26. 26.
    Pinto JA, Pinto HC, Ramalho JR. Laryngeal herpes: a case report. J Voice. 2002;16:560–3.CrossRefPubMedGoogle Scholar
  27. 27.
    Chen PS, Lin YY, Huang BR. Pharyngolaryngeal zoster: a case report. Arch Otolaryngol Head Neck Surg. 2012;138:592–5.CrossRefPubMedGoogle Scholar
  28. 28.
    Shihada R, Brodsky A, Luntz M. Laryngeal mass with multiple cranial neuropathies as a presenting sign for varicella zoster infection. Dysphagia. 2010;25:153–5.CrossRefPubMedGoogle Scholar
  29. 29.
    Higuchi E, Nakamaru Y, Ohwatari R, et al. Laryngeal zoster mimicking a laryngeal cancer. Otolaryngol Head Neck Surg. 2005;133:647.CrossRefPubMedGoogle Scholar
  30. 30.
    Ling L, Zhou SH, Wang SQ. Changing trends in the clinical features of laryngeal tuberculosis: a report of 19 cases. Int J Infect Dis. 2010;2010:e230–5.CrossRefGoogle Scholar
  31. 31.
    Efde MN, Houtman PM, Spoorenberg JPL, et al. Tonsillar tuberculosis in a rheumatoid arthritis patient receiving anti-TNF-alpha (adalimumab) treatment. J Med. 2005;63:112–23.Google Scholar
  32. 32.
    Kolokotronis A, Avramidou E, Zaraboukas T, et al. Oral tuberculosis associated with a treatment with anti-rheumatic drugs. J Oral Pathol Med. 2006;35:123–5.CrossRefPubMedGoogle Scholar
  33. 33.
    Koo S, Marty FM, Baden LR. Infectious complications associated with immunomodulating biologic agents. Infect Dis Clin N Am. 2010;24:285–306.CrossRefGoogle Scholar
  34. 34.
    Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;345:1098.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Wallis RS, Broder MS, Wong JY, et al. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis. 2004;38:1261.CrossRefPubMedGoogle Scholar
  36. 36.
    Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of Candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1–50.CrossRefPubMedGoogle Scholar
  37. 37.
    Gordon DH, Stow NW, Yapa HM, et al. Laryngeal cryptococcosis: clinical presentation and treatment of a rare cause of hoarseness. Otolaryngol Head Neck Surg. 2010;142(3 Suppl 1):S7–9.CrossRefPubMedGoogle Scholar
  38. 38.
    Centers for Disease Control and Prevention (CDC). http://www.cdc.gov/fungal/diseases/histoplasmosis/index.html. Accessed Sept 2017.
  39. 39.
    Baddley JW, Winthrop KL, Patkar NM, et al. Geographic distribution of endemic fungal infections among older persons, United States. Emerg Infect Dis. 2011;17:1664.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Durand ML, Lin DT, Juliano AF, Sadow PM. Case records of the Massachusetts General Hospital. Case 32-2014. A 78-year-old woman with chronic sore throat and a tonsillar mass. N Engl J Med. 2014;371(16):1535–43.CrossRefPubMedGoogle Scholar
  41. 41.
    Goldani LZ, Sugar AM. Dimorphic and miscellaneous fungi. In: Johnson JT, Yu VL, editors. Infectious disease and antimicrobial therapy in ears, nose, and throat. Philadelphia: W. B. Saunders Company; 1997. p. 242–53.Google Scholar
  42. 42.
    Rucci J, Eisinger G, Miranda-Gomez G, et al. Blastomycosis of the head and neck. Am J Otolaryngol. 2014;35(3):390–5.CrossRefPubMedGoogle Scholar
  43. 43.
    Arnold MG, Arnold JC, Bloom DC, et al. Head and neck manifestations of disseminated coccidioidomycosis. Laryngoscope. 2004;114:747–52.CrossRefPubMedGoogle Scholar
  44. 44.
    Galgiani JN. Coccidioides species. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th ed. Churchill Livingstone: London; 2010. p. 3333–44.CrossRefGoogle Scholar
  45. 45.
    Sipp JA, Wise SK, Sobol SE, Yellin SA. Coccidioides immitis: an unexpected fungal pathogen causing retropharyngeal abscess. Otolaryngol Head Neck Surg. 2007;136:500–1.CrossRefPubMedGoogle Scholar
  46. 46.
    Negroni R, Anstead GM, Graybill JR. Paracoccidioidomycosis. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases. 3rd ed. Philadelphia: Elsevier (Saunders); 2011. p. 582–5.Google Scholar
  47. 47.
    Bellissimo-Rodrigues F, Machado AA, Martinez R. Paracoccidioidomycosis epidemiologic features of a 1,000-case series from a hyperendemic area on the southeast of Brazil. Am J Trop Med. 2011;85:546–50.CrossRefGoogle Scholar
  48. 48.
    Brazao-Silva MT, Andrade MF, Franco T, et al. Paracoccidioidomycosis: a series of 66 patients with oral lesions from an endemic area. Mycoses. 2010;54:e189–95.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Infectious Diseases, Department of Medicine, Massachusetts General HospitalHarvard Medical SchoolBostonUSA
  2. 2.Infectious Disease Service, Massachusetts Eye and Ear InfirmaryHarvard Medical SchoolBostonUSA

Personalised recommendations